📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes. (2023)

First Author: Gabizon A

Attributed to: Next generation molecular imaging and therapy with radionuclides funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics15112606

PubMed Identifier: 38004584

Publication URI: http://europepmc.org/abstract/MED/38004584

Type: Journal Article/Review

Volume: 15

Parent Publication: Pharmaceutics

Issue: 11

ISSN: 1999-4923